BR Biomedical Reports 2049-9434 2049-9442 D.A. Spandidos 10.3892/br.2014.402 br-03-02-0189 Articles Association between vitamin D receptor polymorphisms and haplotypes with pulmonary tuberculosis SALIMISAEEDEH 1 2 FARAJIAN-MASHHADIFARZANEH 1 3 ALAVI-NAINIROYA 4 5 TALEBIANGOLBARG 4 NAROOIE-NEJADMEHRNAZ 6 7 Cellular and Molecular Research Center, Zahedan University of Medical Sciences, Zahedan 9816743175, Iran Departments of Clinical Biochemistry and Zahedan University of Medical Sciences, Zahedan 9816743175, Iran Departments of Pharmacology, School of Medicine, Zahedan University of Medical Sciences, Zahedan 9816743175, Iran Infectious Diseases and Tropical Medicine Research Center, Zahedan University of Medical Sciences, Zahedan 9816743175, Iran School of Medicine, Zahedan University of Medical Sciences, Zahedan 9816743175, Iran Department of Genetics, School of Medicine, Zahedan University of Medical Sciences, Zahedan 9816743175, Iran, Zahedan University of Medical Sciences, Zahedan 9816743175, Iran Genetic of Non-Communicable Disease Research Center, Zahedan University of Medical Sciences, Zahedan 9816743175, Iran Correspondence to: Dr Farzaneh Farajian-Mashhadi, Cellular and Molecular Research Center, and Department of Pharmacology, School of Medicine, Zahedan University of Medical Sciences, Khalije Fars High Way, Zahedan 9816743175, Iran E-mail: dr_farajian@yahoo.com 032015 15122014 3 2 189 194 24102014 11112014 Copyright © 2015, Spandidos Publications 2015

The vitamin D receptor (VDR) is an important factor in activating immune response in different infectious diseases. The aim of the present study was to investigate the association between the VDR gene polymorphisms and pulmonary tuberculosis (PTB). The case control study was performed on 120 PTB patients and 131 healthy controls. Genetic analysis was performed by polymerase chain reaction and the restriction fragment length polymorphism method. The VDR Fok1 Ff genotype was associated with TB and the risk of PTB was two times higher in individuals with the Ff genotype. A higher frequency of f allele was observed in PTB patients and therefore, the f allele may be a risk factor for PTB susceptibility. There were no associations between the Taq1 and Bsm1 polymorphisms and PTB. In addition, haplotype analysis showed that the f-T-B and f-t-b haplotypes (Fok1, Taq1 and Bsm1) may have the potential to increase PTB susceptibility. In conclusion, the Ff genotype and f allele of the VDR Fok1 polymorphism were associated with PTB susceptibility. In addition, the f-T-B and f-t-b haplotypes may be the susceptible haplotypes for PTB.

 vitamin D receptor pulmonary tuberculosis gene polymorphism haplotype Introduction

Tuberculosis (TB) is the result of infection with Mycobacterium tuberculosis (M. tuberculosis) and is a significant cause of morbidity and mortality worldwide. Each year >9 million people are infected by TB and >1.7 million succumb to TB annually (1). The incidence of TB in Iran has been reported as 13.7 per 100,000 in 2009; however, its incidence was higher in the Sistan-Balouchestan province, southeastern Iran. The higher incidence is due to bordering with Afghanistan and Pakistan; two countries with a high TB prevalence (2). Cell-mediated immunity is essential for suppression of Mycobacterial infection as it is an intracellular parasite (3). The fact that only 10% of those infected with M. tuberculosis progress to clinical disease revealed that genetic factors, as well as environmental factors are involved in the pathophysiology of TB (4).

In addition, the host genetic basis of TB has been confirmed by twin studies that indicated a two times higher risk of disease in identical twins compared to non-identical twins (5).

Several genes have been found to play a role in TB susceptibility and the relative significance of these genes in disease progression or various forms of disease is often modified by the ethnicity in different populations (6).

The active form of vitamin D, 1-25-dihydroxyvitamin D3, is an important hormone that modulates the activity of different defense and immune cells, including lymphocytes, monocytes, macrophages and epithelial cells (7). Since vitamin D3 increases phagocytosis via the activation of macrophages and affects immune response, it is potentially involved in the development of several diseases (8). Vitamin D3 may limit the growth of M. tuberculosis in macrophages (7). Vitamin D3 exerts its effects through the vitamin D receptor (VDR) and regulates numerous target genes by binding to its nuclear receptor. Active VDR binds to vitamin D response elements that are located in the promoter region of target genes and controls the transcription of these genes (9). The VDR gene is located in chromosome 12cen-q12, including at least five promoter regions, eight exons that code proteins and six untranslated exons, which are alternatively spliced. Since there are several polymorphisms in the VDR gene that may affect VDR activity, those polymorphisms have been known as potential candidates for genetic susceptibility to TB (10, 11).

The Fok1 polymorphism (rs2228570) of the VDR gene, which is located in the translation initiation start site, produces two versions of the VDR protein with different lengths (three amino acids). The short protein, which is encoded by the ‘F’ allele, is more active than the longer one. Additionally, other studies have presented several polymorphisms in strong linkage disequilibrium (LD) in the 3′ untranslated region (3′UTR) of the VDR gene, including Taq1 (rs731236), Bsm1(rs154410) and Apa1(rs7975232). Polymorphisms can be detected by restriction fragment length polymorphism (RFLP). This region of the VDR gene regulates gene expression. Therefore, the polymorphisms that are located in this region may influence VDR activity (12). Thus, the present study was designed to evaluate the possible role of the VDR Fok1, Taq1 and Bsm1 polymorphisms and haplotypes on pulmonary TB (PTB) susceptibility in a local population of southeastern Iran.

 Materials and methods <sec> <title>Patient selection

The case-control study was conducted prospectively at a university-affiliated hospital (Boo-Ali Hospital, Zahedan, southeastern Iran). The hospital is a referral center for TB. The study was conducted between March 2010 and May 2011 and a total of 120 patients were selected. Diagnosis of pulmonary TB was made by clinical findings; positive sputum smear for acid-fast bacilli and the results of chest X-ray, but only patients who were confirmed by culture were included in the study. Patients affected with other diseases or conditions, such as myocardial infarction, cirrhosis, acute pancreatitis and septic shock, were excluded from the study. A total of 131 normal healthy subjects who underwent the physical examination at Boo-Ali Hospital were recruited during the study period and were matched for age, gender, ethnicity and geographical origin to patients. The inclusion criteria for normal healthy subjects were absence of clinical symptoms and signs suggestive of active PTB and had a normal chest X-ray. No medical history of TB or other infectious diseases, autoimmune diseases, cancer or other diseases that affect host immunity were observed in the control group. C reactive protein (CRP) was measured for the control group and only negative CRP results were used in the final analysis. The Dean for research affairs of the University Ethics Committee approved the protocol prior to commencing the study.

 DNA extraction

Genomic DNA was extracted from 200 µ1 of peripheral blood in EDTA using the DNA extraction kit (Roche Diagnostics, Mannheim, Germany).

 Genotyping of VDR Fok1, Taq1 and Bsm1 polymorphisms

Genotypes were detected using a polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP). The primer sequences, annealing temperature, restriction enzymes and fragments sizes are shown in Table I. PCR was performed in a 25 µ1 final volume containing 25 pmol of each primer, 0.1 mmol/1 dNTP (Fermentas, Lithuania), 0.3 µg genomic DNA, 1.5 mmol/1 MgCl2, 2.5 µ1 10X PCR buffer and 1.5 units Taq DNA polymerase (Fermentas), according to the following protocol: Initial denaturation at 94˚C for 4 min; 30 cycles of denaturation at 94˚C for 45 sec, annealing for 30 sec and extension at 72˚C for 45 sec; and final extension at 72˚C for 5 min. The PCR products were digested overnight with Fok1, Taq1 and Bsm1 restriction endonucleases (Fermentas) and visualized in 2.5% agarose gel electrophoresis.

The presence and absence of a restriction site were assigned a lowercase and uppercase letter, respectively (a and A for Apa1, t and T for Taq1, f and F for Fok1, b and B for Bsm1).

 Statistical analysis

The statistical analysis of the data was performed using SPSS software for Windows, version 20 (SPSS, Inc., Chicago, IL, USA). The differences between the groups were analyzed by independent sample t-test, χ2 test or Fisher's exact test, as appropriate. The χ2 test was used for deviation of genotype distribution from the Hardy-Weinberg equilibrium. Allele frequencies were calculated by the gene counting method. The odds ratio (OR) and 95% confidence interval (CI) for each variable were also estimated. The frequency of haplotypes was calculated using PHASE software, version 2.1 (13). Logistic regression analysis was used to assess the independent effect of each risk polymorphism and haplotypes on TB. Bonferroni's post hoc correction was applied to confirm the association of haplotypes with the disease. A two-sided significance level of 0.05 was considered to indicate a statistically significant difference. The computation of LD between single-nucleotide polymorphisms (SNPs) was estimated using the normalized measure of allelic association D' and the characterization of these patterns was determined using Haploview software, version 4.2 (http://www.broad.mit.edu/mpg/haploview).

 Results <sec> <title>Patient characteristics

The demographic and clinical characteristics of PTB patients and controls are shown in Table II. There was no statistically significant difference in gender, age and ethnic characteristics in the patients compared to the control subjects. The frequency of smokers was significantly higher in the PTB patients compared to controls (47 vs. 35; P=0.0001).

 Genotype frequencies

The genotype and allele frequencies of VDR polymorphisms in PTB patients and healthy controls are shown in Table III. All loci conformed to the Hardy-Weinberg equilibrium in the patient and control groups (P>0.05).

The frequency of the VDR Ff genotype was significantly higher in PTB patients compared to controls and the PTB risk was two times higher in individuals with Ff genotype prior and subsequent to adjustment for age, gender, smoking and ethnicity.

However, the frequency of the ff genotype was not different between the two groups prior and subsequent to adjustment for age, gender, smoking and ethnicity. A higher frequency of the f allele was observed in TB patients and the f allele may be a risk factor for PTB predisposition (OR, 1.8; 95% CR, 1.2–2.8; P=0.006). These findings showed that there were no significant difference regarding VDR Bsm1 and Taq1 polymorphisms among the PTB patients and control group.

The LD patterns of the three VDR SNPs are shown in Fig. 1. The frequency of seven common haplotypes of the three VDR SNPs [Fok1(C/T), Taq1(T/C) and Bsm1(A/G)] are shown in Table IV. The frequency of f-T-B and f-t-b haplotypes was significantly higher in PTB patients compared to controls and haplotype-based association analysis revealed that the f-T-B and f-t-b haplotypes may have the potential to increase PTB susceptibility (OR, 1.3; 95% CR, 1.1-1.5; P=0.014 and OR, 1.1; 95% CR, 1–1.2; P=0.012 respectively). The association was also statistically significant following post hoc Bonferroni's correction.

 Discussion

TB is a global health problem and its incidence is not the same in different countries, ethnic groups and populations. Much evidence supports an important role for host genetic variations in the predisposition to TB, therefore, the combination effect of genetic and environmental factors may influence the development of TB (14). In addition, there is other evidence that emphasizes the variations in ethnicity for the susceptibility to TB (15). Different candidate genes have been examined in associated studies to evaluate the identity of the TB ‘susceptibility factors,’ including human leukocyte antigen (16, 17), natural-resistance-associated macrophage protein 1 (16, 17), VDR (11, 16), cluster of differentiation 14 (18), interleukins (19) and Toll-like receptors (20).

Several studies have reported a higher frequency of vitamin D deficiency among TB patients and high doses of vitamin D were extensively used for TB treatment (11, 21). In vivo studies showed that vitamin D suppressed intracellular growth of M. tuberculosis (22). Cathelicidin expression, which is the first line of defense in patients, is induced by vitamin D (23).

The active form of vitamin D can lead to macrophage activation and subsequently limit the intracellular growth of M. tuberculosis. This vitamin exerts its effect via binding to VDR in the monocytes, therefore the VDR gene polymorphisms are suggested to be involved in genetic susceptibility to TB (24). The association between the VDR polymorphisms and TB susceptibility has been studied in different populations and the results were contradictory (10, 25–27).

In the present study, a higher frequency of the VDR Ff genotype of the Fok1 polymorphism was observed in the patients compared to the controls. Therefore, this genotype may be considered as a genetic risk factor for the PTB susceptibility. Additionally, the presence of the Fok1 mutated allele (f allele), either in the heterozygous or homozygous state, increased the disease risk.

There were no associations between the VDR Taq1 and Bsm1 polymorphisms and PTB. The frequency of the f-T-B and f-t-b haplotypes of the VDR Fok1(C/T), Taq1(T/C) and Bsm1(A/G) polymorphisms were significantly higher in PTB patients.

An association between 25-hydroxycholecalciferol deficiency and occurrence of TB among the Gujarati Asian population in west London has been reported previously. In addition, a significant interaction between the vitamin D status and Fok1 and Taq1 polymorphisms and TB was observed (11).

There was an association between ff genotype of Fok1 but not Taq1 polymorphism and susceptibility to PTB in Chinese Han population (25).

Although there has not been any reported association between the VDR Taq1 and Fok1 polymorphisms and PTB susceptibility in Peru, an association between the VDR gene polymorphism and response to treatment of PTB has been observed (26). In a case control study in West Africa, no association between TB and the VDR Fok1, Bsm1, Apa1 and Taq1 variants was reported; however, the FA haplotype of the Fok1 and Apa1 polymorphisms was correlated with TB susceptibility (10). Although the study by Lombard et al (28) did not report any correlation between the VDR Fok1, Bsm1, Apa1 and Taq1 polymorphisms and TB, the F-b-A-T haplotype was observed as a protective factor for TB in South Africa.

Similar to the results of the present study, the association between the Fok1 polymorphism, but not the Taq1 polymorphism, of the VDR gene with PTB has been observed in the Chinese Tibetan population (29).

The results of Alagarasu et al (30) indicated that the b-A-T haplotype of the 3′UTR VDR gene played a protective role against human immunodeficiency virus (HIV) infection, whereas the B-A-t haplotype may be associated with susceptibility to the development of TB in HIV-1-infected patients.

In contrast to the results of the present study, Banoei et al (31) revealed that the tt and bb genotypes of the VDR Taq1 and Bsm1 polymorphisms are associated with the predisposition to PTB in an Iranian population. In another study, Merza et al (32) also confirmed the association of the VDR Bsm1 (Bb + bb) polymorphism and PTB in a local Iranian population.

In a meta-analysis that was performed on 23 studies in 2010, an association between the Fok1 ff genotype and TB has been observed among the Asian population (OR, 2.0; 95% CR, 1.3-3.2). Additionally a significant inverse association was observed for the Bsm1 bb genotype (OR, 0.5; 95% CR, 0.4-0.8). There were no associations between these polymorphisms and TB among the African or South American populations (27). The association between the VDR Fok1 polymorphism and extra-PTB and spinal TB has been reported in American and Chinese Han populations, respectively (33, 34).

In another study, no correlation between the Taq1, Bsm1 and Fok1 polymorphisms were found for host susceptibility to human TB in the Korean population (35).

Consistent with the findings of the present study, a higher frequency of the Fok1 Ff and ff genotypes in TB patients has been reported in the Chinese Kazak population. There were no significant differences of the Taq1-Tt and tt genotype frequencies between TB patients and healthy controls (16).

Although the reason for this discrepancy remains unclear, these different results in the association studies are common and may be due to the different genetic background of various populations, different selection criteria adopted for patients and controls in particular clinical presentation and environmental risk factors.

There were certain limitations in the present study, such as a small sample size and different ethnic groups (Fars and Balouch) existing in southeast Iran. Therefore, further investigations using a larger sample size and different ethnic groups are necessary to confirm the present results.

In conclusion, the results showed that the VDR Ff genotype and f allele of the Fok1 polymorphism was associated with PTB susceptibility. There were no associations between the VDR Taq1 and Bsm1 polymorphisms and PTB. In addition, the frequency of the f-T-B and f-t-b haplotypes was significantly higher in the PTB patients.

 Acknowledgements

The present study was extracted from the Master of Science thesis (Comparison of VDR gene polymorphisms frequency in PTB patients and healthy controls. Zahedan University of Medical Sciences. Registered no. 1312) at Zahedan University of Medical Sciences. The authors would like to thank the Deputy of Research Affairs at the University for funding this project.

 References Global tuberculosis controlWHO report 2010World Health OrganizationGeneva, Switzerland2010(WHO/HTM/TB/2010.7) Centers for Disease Control and PreventionReported tuberculosis in Sistan and BaluchestanIran. CDCAtlanta, GA2009 FlynnJLChanJImmunology of tuberculosisAnnu Rev Immunol1993129200110.1146/annurev.immunol.19.1.9311244032 CasanovaJLAbelLGenetic dissection of immunity to mycobacteria: the human modelAnnu Rev Immunol20581620200210.1146/annurev.immunol.20.081501.12585111861613 ComstockGWTuberculosis in twins: a re-analysis of the Prophit surveyAm Rev Respir Dis1176216241978565607 BlackwellJMGenetics and genomics in infectious disease susceptibilityTrends Mol Med7521526200110.1016/S1471-4914(01)02169-411689339 BellamyRRuwendeCCorrahTTuberculosis and chronic hepatitis B virus infection in Africans and variation in the vitamin D receptor geneJ Infect Dis179721724199910.1086/3146149952386 Bar-ShavitZNoffDEdelsteinSMeyerMShiboletSGoldmanR1,25-dihydroxyvitamin D3 and the regulation of macrophage functionCalcif Tissue Int33673676198110.1007/BF024095076275970 HausslerMRHausslerCABartikLVitamin D receptor: molecular signaling and actions of nutritional ligands in disease preventionNutr Rev66(Suppl 2)S98S112200810.1111/j.1753-4887.2008.00093.x18844852 BornmanLCampbellSJFieldingKVitamin D receptor polymorphisms and susceptibility to tuberculosis in West Africa: a case-control and family studyJ Infect Dis19016311641200410.1086/42446215478069 WilkinsonRJLlewelynMToossiZInfluence of vitamin D deficiency and vitamin D receptor polymorphisms on tuberculosis among Gujarati Asians in west London: a case-control studyLancet355618621200010.1016/S0140-6736(99)02301-610696983 UitterlindenAGFangYVan MeursJBPolsHAVan LeeuwenJPGenetics and biology of vitamin D receptor polymorphismsGene338143156200410.1016/j.gene.2004.05.01415315818 ScheetPStephensMA fast and flexible statistical model for large-scale population genotype data: applications to inferring missing genotypes and haplotypic phaseAm J Hum Genet78629644200610.1086/50280216532393 MathemaBKurepinaNEBifaniPJKreiswirthBNMolecular epidemiology of tuberculosis: current insightsClin Microbiol Rev19658685200610.1128/CMR.00061-0517041139 HoalEGHuman genetic susceptibility to tuberculosis and other mycobacterial diseasesIUBMB Life53225229200210.1080/1521654021264412121000 WuFZhangWZhangLNRAMP 1, VDR, HLA-DRB 1, and HLA-DQB1 gene polymorphisms in susceptibility to tuberculosis among the Chinese Kazakh population: a case-control studyBiomed Res Int2013484535201310.1155/2013/48453524024195 BellamyRRuwendeCCorrahTMcAdamKPWhittleHCHillAVVariations in the NRAMP1 gene and susceptibility to tuberculosis in West AfricansN Engl J Med338640644199810.1056/NEJM1998030533810029486992 Alavi-NainiRSalimiSSharifi-MoodBDavoodikiaAAMoodyBNaghaviAAssociation between the CD14 gene C-159T polymorphism and serum soluble CD14 with pulmonary tuberculosisInt J Tuberc Lung Dis1613831387201210.5588/ijtld.11.082723107636 TrajkovDTrajchevskaMArsovTAssociation of 22 cytokine gene polymorphisms with tuberculosis in MacedoniansIndian J Tuberc56117131200920349753 JahantighDSalimiSAlavi-NainiREmamdadiAOwaysee OsqueeHFarajian MashhadiFAssociation between TLR4 and TLR9 gene polymorphisms with development of pulmonary tuberculosis in Zahedan, southeastern IranScientific World Journal2013534053201310.1155/2013/53405323766695 NursyamEWAminZRumendeCMThe effect of vitamin D as supplementary treatment in patients with moderately advanced pulmonary tuberculous lesionActa Med Indones3835200616479024 RockettKABrookesRUdalovaIVidalVHillAVKwiatkowskiD1,25-Dihydroxyvitamin D3 induces nitric oxide synthase and suppresses growth of Mycobacterium tuberculosis in a human macrophage-like cell lineInfect Immun665314532119989784538 GombartAFThe vitamin D-antimicrobial peptide pathway and its role in protection against infectionFuture Microbiol411511165200910.2217/fmb.09.8719895218 HerrCGreulichTKoczullaRAThe role of vitamin D in pulmonary disease: COPD, asthma, infection, and cancerRespir Res1231201110.1186/1465-9921-12-3121418564 LiuWCaoWCZhangCYVDR and NRAMP1 gene polymorphisms in susceptibility to pulmonary tuberculosis among the Chinese Han population: a case-control studyInt J Tuberc Lung Dis8428434200415141734 RothDESotoGArenasFAssociation between vitamin D receptor gene polymorphisms and response to treatment of pulmonary tuberculosisJ Infect Dis190920927200410.1086/42321215295697 GaoLTaoYZhangLJinQVitamin D receptor genetic polymorphisms and tuberculosis: updated systematic review and meta-analysisInt J Tuberc Lung Dis141523201020003690 LombardZDaltonDLVenterPAWilliamsRCBornmanLAssociation of HLA-DR, -DQ, and vitamin D receptor alleles and haplotypes with tuberculosis in the Venda of South AfricaHum Immunol67643654200610.1016/j.humimm.2006.04.00816916662 ChenXRFengYLMaYStudy on the association of two polymorphisms of the vitamin D receptor (VDR) gene with the susceptibility to pulmonary tuberculosis (PTB) in Chinese TibetansSichuan Da Xue Xue Bao Yi Xue Ban378478512006(In Chinese)17236578 AlagarasuKSelvarajPSwaminathanSNarendranGNarayananPR5′ regulatory and 3′ untranslated region polymorphisms of vitamin D receptor gene in south Indian HIV and HIV-TB patientsJ Clin Immunol29196204200910.1007/s10875-008-9234-z18712587 BanoeiMMMirsaeidiMSHoushmandMVitamin D receptor homozygote mutant tt and bb are associated with susceptibility to pulmonary tuberculosis in the Iranian populationInt J Infect Dis14e84e85201010.1016/j.ijid.2009.05.00119482503 MerzaMFarniaPAnooshehSThe NRAMPI, VDR and TNF-alpha gene polymorphisms in Iranian tuberculosis patients: the study on host susceptibilityBraz J Infect Dis13252256200910.1590/S1413-8670200900040000220231985 Motsinger-ReifAAAntasPROkiNOLevySHollandSMSterlingTRPolymorphisms in IL-1beta, vitamin D receptor Fok1, and Toll-like receptor 2 are associated with extrapulmonary tuberculosisBMC Med Genet1137201010.1186/1471-2350-11-3720196868 ZhangHQDengAGuoCFAssociation between FokI polymorphism in vitamin D receptor gene and susceptibility to spinal tuberculosis in Chinese Han populationArch Med Res414649201010.1016/j.arcmed.2009.12.00420430254 KangTJJinSHYeumCEVitamin D receptor gene TaqI, BsmI and FokI polymorphisms in Korean patients with tuberculosisImmune Netw11253257201110.4110/in.2011.11.5.25322194708

Linkage disequilibrium pattern of three single nucleotide polymorphisms in the vitamin D receptor gene.

Primer sequences, annealing temperature, restriction enzymes and fragment sizes of the vitaminD receptor gene polymorphisms.

Target sequence Primer sequence Annealing temperature, °C PCR product RFLP fragments Refs
Fok1 F: 5′-AGCTGGCCCTGGCACTGACTCTGGCT-3′ 57 267 F(C): 305
R: 5′-ATGGAAACACCTTGCTTCTTCTCCCTC-3′ f(T): 115, 190 11
Taq1 F: 5′-GGGACGATGAGGGATGGACAGAGC-3′ 61 716 T(T): 512, 204
R: 5′-GGAAAGGGGTTAGGTTGGACAGGA-3′ t(C): 311, 201, 204 11
Bsm1 F: 5′-AACTTGCATGAGGAGGAGCATGTC-3′ 61 813 B(A): 813
R: 5′-GGAGAGGAGCCTGTGTCCCATTTG-3′ b(G): 335, 478 11

PCR, polymerase chain reaction; RFLP, restriction fragment length polymorphism.

Demographic characteristics of pulmonary tuberculosis (PTB) patients and controls.

Variables PTB n=120 Controls n=131 P-value OR (95%CI)
Age, years 51.5±19.7 48.1±12.2 0.1
Gender (M/F) 45/75 38/93 0.09
Smoking, n (%) 47 (39) 35 (27) 0.0001 3.2 (1.8-5.8)
Race, n (%) 0.1
  Persian 46 (38) 34 (26)
  Balouch 70 (59) 90 (69)
  Afghan 4 (3) 7 (5)

OR, odds ratio; CI, confidence interval; M, male; F, female.

Genotype and allele frequencies of vitaminD receptor (VDR) gene polymorphisms in pulmonary tuberculosis (PTB) patients and healthy controls.

VDR polymorphisms PTB, n=120 (%) Controls, n=131 (%) P-value OR (95% CI) P-value ORa (95% CI)
Fok1
  FF 65 (54) 93 (71) 1
  Ff 44 (37) 31 (24) 0.013 2.0 (1.2-3.6) 0.015 2.0 (1.2-3.6)
  ff 11 (9) 7 (5) 0.1 1.5 (0.9-2.5) 0.08 1.6 (1-2.6)
  Ff + ff 55 (46) 38 (29) 0.006 2.1 (1.2-3.5) 0.006 2.1 (1.2-3.6)
  F 174 (73) 217 (83) 1 −
  f 66 (27) 45 (17) 0.006 1.8 (1.2–2.8)
  Taq1
    TT 52 (43) 67 (51) 1
    Tt 54 (45) 50 (38) 0.2 1.4 (0.8-2.4) 0.17 1.5 (0.9-2.5)
    tt 14 (12) 14 (11) 0.6 1.1 (0.8-1.7) 0.5 1.2 (0.8-1.8)
    Tt+tt 68 (57) 64 (49) 0.2 1.4 (0.8-2.3) 0.2 1.4 (0.9-2.3)
    T 158 (66) 184 (70) 1 −
    t 82 (34) 78 (30) 0.3 1.2 (0.8-1.8) −
  Bsm1
    BB 31 (26) 39 (30) 1
    Bb 66 (55) 70 (53) 0.6 1.2 (0.7-2.1) 0.7 1.1 (0.6-2)
    bb 23 (19) 22 (17) 0.5 1.2 (0.8-1.7) 0.4 1.2 (0.8-1.7)
    Bb+bb 89 (74) 92 (70) 0.5 1.2 (0.7-2.1) 0.6 1.2 (0.7-2.1)
    B 128 (53) 148 (57) 1
    b 112 (47) 114 (43) 0.5 1.1 (0.8-1.6)

OR, adjusted OR for age, gender, smoking and ethnicity. OR, odds ratio; CI, confidence interval.

Haplotypes frequency of vitaminD receptor gene polymorphisms in pulmonary tuberculosis (PTB) patients and controls.

Fok1 Taq1 Bsm1 PTB % Control % P-value OR (95% CI)
F T B 39.2 47.7 1
F T b 15.8 14.9 0.3 1.3 (0.8-2.2)
F t B 4.2 4.2 0.7 1.1 (0.7-1.7)
F t b 13.3 16 0.96 1.0 (0.8-1.2)
f T B 9.6 4.6 0.014 1.3 (1.1-1.5)
f T b 1.2 3.1 0.3 0.9 (0.7-1.1)
f t b 16.2 9.5 0.012 1.1 (1-1.2)

OR, odds ratio; CI, confidence interval.